You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024


✉ Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for HYDROFLUMETHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants


See all HYDROFLUMETHIAZIDE clinical trials

Medical Subject Heading (MeSH) Categories for HYDROFLUMETHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for HYDROFLUMETHIAZIDE

US Patents and Regulatory Information for HYDROFLUMETHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088932-001 Jan 11, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs HYDROFLUMETHIAZIDE hydroflumethiazide TABLET;ORAL 088528-001 Aug 15, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Shire SALUTENSIN hydroflumethiazide; reserpine TABLET;ORAL 012359-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.